Sickle Cell Disease Drug Pulled From Global Markets Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
FDA Expands Approval of Osimertinib in Lung Cancer EGFR inhibitor now indicated for unresectable stage III disease following chemoradiotherapy Sep 25, 2024
Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic Actual rates for 2021 lagged behind projections Sep 25, 2024
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion Sep 25, 2024
Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer Strategy comes with associated "low risk" of delay in diagnosis of advanced or incurable cancers Sep 25, 2024
'Sex Party' COVID Czar Fired; Undiagnosed Iron Deficiency; Many Papers Partly Fake? Health news and commentary gathered by 名媛直播 staff Sep 25, 2024
ASCO's Quality Care Symposium: Chemotherapy Shortage Resulted in Higher Costs Other studies look at financial toxicity for teen/young adult cancer patients, nausea after chemo Sep 24, 2024
Immunotherapy May Not Benefit All Gastroesophageal Cancer Patients, FDA Staff Says Data since approvals suggest benefits limited to subgroups with PD-L1 expression of at least 1% Sep 24, 2024
EPA Scientists Say They Were Pressured to Downplay Health Harms From Chemicals And a watchdog found they were retaliated against Sep 22, 2024
High ADHD Medication Doses Tied to Psychosis; Rapid Tests for Malaria Also in TTHealthWatch: youth and opioids, and pembrolizumab for triple-negative breast cancer Sep 21, 2024 podcast
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms? News, features, and commentary about cancer-related issues Sep 19, 2024
Rucaparib-Nivolumab Maintenance Not the Answer in Newly Diagnosed Ovarian Cancer Poorer survival outcomes plus more toxicity versus rucaparib alone Sep 18, 2024
Novel Agent Effective for Cancer Wasting Disorder Cancer patients with cachexia added needed pounds with GDF-15 antibody Sep 18, 2024
Lymphedema Risk No Higher With 3-Week RT Regimen in Early Breast Cancer "Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says Sep 17, 2024
FDA Expands Approval of Ribociclib to Early Breast Cancer Broad indication doubles the number of patients eligible for adjuvant CDK4/6 inhibition Sep 17, 2024
Survival Win for Pembrolizumab in Early Triple-Negative Breast Cancer Absolute difference of 4.9% at 5 years, including a benefit for patients who did not achieve pCR Sep 17, 2024
Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors Potential new option for patients with previously treated extrapancreatic or pancreatic NETs Sep 17, 2024
Digital Breast Tomosynthesis May Reduce Development of Advanced Cancers Retrospective study suggests benefits over digital mammography Sep 17, 2024
Win for Perioperative Durvalumab in Muscle-Invasive Bladder Cancer Results "practice-changing," says expert Sep 16, 2024
Medical Cannabinoids in Kids Linked to These Adverse Events Meta-analysis points to considerations for use and what to monitor Sep 16, 2024
Another Possible Treatment Option for Intermediate-Stage Liver Cancer Adding lenvatinib, pembrolizumab to TACE significantly improved PFS, numerically improved OS Sep 16, 2024
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation Regimen tops best historical response rate with chemoimmunotherapy in this setting Sep 16, 2024
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival Hazards for radiographic PFS, OS reduced by 31% with enzalutamide plus Ra-223 Sep 15, 2024
Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer POD1UM-303/InterAACT 2 data also trend in the direction of better overall survival Sep 15, 2024
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer But combination may be appropriate for shrinking tumors before surgery Sep 14, 2024
Another Win for Antibody-Drug Conjugate in HER2+ Breast Cancer With Brain Mets Second-line T-DXd best option in patients with and without intracranial activity, experts says Sep 14, 2024
Screening After False Positive Mammograms; RSV Vaccination and Hospitalization Also in TTHealthWatch: time from approval to reimbursement for new drugs Sep 14, 2024 podcast
No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma Data support that ICI rechallenge should be discouraged in patients with advanced RCC Sep 13, 2024
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer News, features, and commentary about cancer-related issues Sep 12, 2024
How a California Oncologist Making $850k Spends Money See the breakdown of this physician's weekly budget, from eating out to sailing lessons Sep 12, 2024
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments Incidence almost identical to that with standard cancer treatment in randomized trials Sep 11, 2024
Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC Objective response rate was 55% with 12-mg/kg ifinatamab deruxtecan Sep 11, 2024
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors "This is sort of the dirty underbelly of the current healthcare environment," an oncologist said Sep 11, 2024
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC However, plinabulin plus docetaxel still "not ready for prime time," expert says Sep 10, 2024
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC Absolute improvement of almost 30%, doubling of duration of response with savolitinib Sep 10, 2024
Did U.S. Government Play a Role in Remote Tribe's Widespread Illness and Cancer? Toxins are embedded in the soil, but no one can say what has caused such widespread illness Sep 10, 2024
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC Two-trial analysis shows about a 40% decreased risk of disease recurrence or death Sep 09, 2024
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline Sep 09, 2024
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC Novel agent nearly halved risk of progression as first-line therapy in phase III trial Sep 09, 2024
Kate Middleton Reaches Cancer Treatment Milestone Princess of Wales says she will return to some public duties Sep 09, 2024
